Genelux Corp. (GNLX)
2.66
-0.22
(-7.64%)
USD |
NASDAQ |
Aug 28, 16:00
2.665
0.00 (0.00%)
After-Hours: 20:00
Genelux Market Cap : 119.98M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 119.98M |
| August 27, 2026 | 129.90M |
| August 26, 2026 | 123.13M |
| August 25, 2026 | 122.68M |
| August 24, 2026 | 122.68M |
| August 21, 2026 | 122.68M |
| August 20, 2026 | 123.58M |
| August 19, 2026 | 120.88M |
| August 18, 2026 | 117.27M |
| August 17, 2026 | 121.78M |
| August 14, 2026 | 123.58M |
| August 13, 2026 | 118.62M |
| August 12, 2026 | 121.78M |
| August 11, 2026 | 119.52M |
| August 10, 2026 | 122.68M |
| August 07, 2026 | 119.28M |
| August 06, 2026 | 121.07M |
| August 05, 2026 | 112.55M |
| August 04, 2026 | 126.45M |
| August 03, 2026 | 133.62M |
| July 31, 2026 | 131.83M |
| July 30, 2026 | 136.76M |
| July 29, 2026 | 126.90M |
| July 28, 2026 | 130.93M |
| July 27, 2026 | 132.28M |
| Date | Value |
|---|---|
| July 24, 2026 | 129.59M |
| July 23, 2026 | 132.73M |
| July 22, 2026 | 132.73M |
| July 21, 2026 | 129.59M |
| July 20, 2026 | 131.38M |
| July 17, 2026 | 128.69M |
| July 16, 2026 | 126.45M |
| July 15, 2026 | 130.49M |
| July 14, 2026 | 129.59M |
| July 13, 2026 | 132.73M |
| July 10, 2026 | 135.87M |
| July 09, 2026 | 133.62M |
| July 08, 2026 | 132.73M |
| July 07, 2026 | 133.18M |
| July 06, 2026 | 135.42M |
| July 02, 2026 | 134.07M |
| July 01, 2026 | 130.04M |
| June 30, 2026 | 134.97M |
| June 29, 2026 | 130.04M |
| June 26, 2026 | 128.69M |
| June 25, 2026 | 130.04M |
| June 24, 2026 | 127.80M |
| June 23, 2026 | 130.93M |
| June 22, 2026 | 130.93M |
| June 18, 2026 | 132.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcutis Biotherapeutics, Inc. | 2.987B |
| ACADIA Pharmaceuticals, Inc. | 5.011B |
| Alnylam Pharmaceuticals, Inc. | 31.71B |
| Anika Therapeutics, Inc. | 282.38M |
| Savara, Inc. | 1.080B |
Market Cap Related Metrics
| PS Ratio | 13691.48 |
| PEG Ratio | -2.366 |
| Price to Book Value | 7.446 |
| Price | 2.66 |
| Earnings Yield | -32.63% |
| PEGY Ratio | -2.366 |